4 results about "Chronic cough" patented technology

Use of a RASP inhibitor in the treatment of chronic cough, asthma and alcoholic liver disease. The RASP inhibitor includes a compound represented by formula (II) or a pharmaceutically acceptable salt or crystal form thereof. And has good efficacy in animal model experiments of diseases such as chronic cough, asthma and alcoholic liver disease.

1. Name of the product in this design: Fog reservoir (for both mouth and nose). 2. Intended use of this design: an inhalation device for the simultaneous treatment of rhinitis, asthma, adenoid hypertrophy, allergic rhinitis-asthma syndrome, chronic cough, and COPD. 3. The key design feature of this product is its shape. 4. The picture or photo that best illustrates the key design points: Design 1 Combined State Diagram 1. 5. Design 1 is designated as the basic design. 6. Other situations requiring explanation: In the 3D diagram of component 1, part A is made of transparent material.

The application belongs to the technical field of Chinese patent medicines, and provides a use of Guiling tablets in the preparation of a medicine for treating stress urinary incontinence or bladder cough. On the basis of the known efficacy of Guiling tablets, a commercially available Chinese patent medicine, for treating kidney deficiency causing asthma and lung deficiency causing chronic cough, the application uses the kidney tonifying and qi consolidating effect of Guiling tablets to treat stress urinary incontinence or bladder cough, and very significant effects are observed on the incontinence of urine caused by excessive cough and asthma due to kidney deficiency in the middle-aged and the elderly, especially in middle-aged and elderly women.

The present invention relates to salt derivatives of (R)-6-(5-fluoropyridine-2-yl)-8-methoxy-N-(1-(5-methyl-1,2,4-oxadiazole-3-yl)ethyl)quinazoline-4-amine, and more particularly to mesylates and esylates of (R)-6-(5-fluoropyridine-2-yl)-8-methoxy-N-(1-(5-methyl-1,2,4-oxadiazole-3-yl)ethyl)quinazoline-4-amine, pharmaceutical compositions containing them, and their therapeutic uses. The salts of the present invention may be useful in the treatment of respiratory diseases, particularly diseases or conditions associated with chronic cough.